Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Analysis of initial poor graft function after orthotopic liver transplantation: experience of an australian single liver transplantation center
2002
Hepatocellular carcinoma
2003 Standout
Liver Transplantation for Hepatocellular Carcinoma
1998
A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors1
2004
A proposal for scoring marginal liver grafts
2000
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
Hepatitis C Virus–Specific CD4+T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease
2001 StandoutNobel
Peginterferon alfa‐2a for hepatitis C after liver transplantation
2005
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
2002 Standout
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
2007
Tacrolimus is superior to cyclosporine in liver transplantation
1998
Liver fibrosis
2005 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center
2008
Systematic grading of surgical complications in live liver donors according to Clavien's system
2006
Living Donor Liver Transplantation for Adult Patients With Hepatocellular Carcinoma
2004
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
2008
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Use of the Molecular Adsorbents Recirculating System as a Treatment for Acute Decompensated Wilson Disease
2008
Liver transplantation in patients with hepatocellular carcinoma across Milan criteria
2008
Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma
2017
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
2010 Standout
A randomized controlled trial of lamivudine to treat acute hepatitis B
2006
The utility of marginal donors in liver transplantation
2003
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Hepatocellular carcinoma
2012 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative Imaging
2007
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Hepatitis C and liver fibrosis
2003
Skin Cancers after Organ Transplantation
2003 Standout
Management of Urinary Tract Infections and Lymphocele in Renal Transplant Recipients
2001
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Management of Hepatocellular Carcinoma *
2005 Standout
Prevention and treatment of hepatitis C virus recurrence after liver transplantation
2004
Serum Vascular Endothelial Growth Factor Predicts Venous Invasion in Hepatocellular Carcinoma : A Prospective Study
2001
Liver Transplantation for Hepatocellular Carcinoma
2008
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
2008
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
The use of lamivudine for patients with acute hepatitis B (a series of cases)
2004
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
2004 Standout
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas
2002
Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
2005
Utilization of Extended Donor Criteria Liver Allografts Maximizes Donor Use and Patient Access to Liver Transplantation
2005
Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients1.
2002
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
2011
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial
2001
Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
2002
Chronic hepatitis B
2007 Standout
Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy
2004
Wilson's disease and other neurological copper disorders
2014
Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups
2008
Chronic hepatitis B: Update 2009 #
2009 Standout
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Hepatitis C virus genotypes and quasispecies
1999
Resection and Liver Transplantation for Hepatocellular Carcinoma
2005
Morbidity and mortality of recurrent hepatitis C infection after orthotopic liver transplantation
1997
Impact of human leukocyte antigen matching in liver transplantation
2003
Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysis
2004
Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor
2009
Wilson disease in children
2017
Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection
2001
Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study
2003
Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
2000
Recurrent hepatitis C genotype 1b following liver transplantation
2004
Treatment of Patients with Recurrent Hepatitis C after Liver Transplantation with Peginterferon Alfa-2B Plus Ribavirin
2006
Infection in Solid-Organ Transplant Recipients
2007 Standout
Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis
2009
Difference in Tumor Invasiveness in Cirrhotic Patients With Hepatocellular Carcinoma Fulfilling the Milan Criteria Treated by Resection and Transplantation
2006
A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system
2010
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Evolution of Hepatitis B Virus Polymerase Gene Mutations in Hepatitis B E Antigen-Negative Patients Receiving Lamivudine Therapy
2000
Hepatocellular Carcinoma
2011 Standout
Diagnosis and management of fulminant Wilson’s disease: a single center’s experience
2015
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study
2007
OUTCOME OF TRANSPLANTATION OF ORGANS PROCURED FROM BACTEREMIC DONORS1
1999
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
Extended-Donor Criteria Liver Allografts
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation
2004
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
1998
A proposal for scoring marginal liver grafts
2000
Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective
2005
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function
2002
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
Evaluation of potential liver donors: Limits imposed by donor variables in liver transplantation
2003
Heavy Metals and Pesticides Toxicity in Agricultural Soil and Plants: Ecological Risks and Human Health Implications
2021 Standout
Hepatitis C and liver transplantation
2001
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
Developments in liver transplantation
2004
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Works of D Forti being referenced
Is lymphocele in renal transplantation an avoidable complication?
2000
Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?
1997
Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation
1996
Right lobe living-related liver transplant
2003
Lamivudine treatment for acute hepatitis B after liver transplantation
1998
Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation
2000
Marginal donors in liver transplantation: the role of donor age
1999
Treatment of HCC: the role of liver resection in the era of transplantation
2001
Liver transplantation for hepatocellular carcinoma: prognostic factors associated long-term survival
1996
Posttransplant lymphoproliferative disorders: report from a single center
2001
Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study
2001
Surgical Treatment of Hepatocellular Cancer in the Era of Hepatic Transplantation
2003
Early steroid withdrawal in liver transplant patients: Final report of a prospective randomized trial
1997
Liver Transplantation for Wilson'S Disease
2005
Predictors of Long-Term Survival After Liver Transplantation for Hepatocellular Carcinoma
2005
Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?
2003
[Surgical treatment of hepatocellular carcinoma: resection or transplantation? Results of a multivariate analysis].
2002
Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria
1996
Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?
2003
Liver transplantation for hepatocellular carcinoma: prognostic factors associated long-term survival
1996